Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bellitics
- Development stage
- Unknown
- Lead developer
- Wonne International
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Bellitics is a combination probiotic, prebiotic, and mineral supplement developed and marketed by Wonne International. Formulated as oral sachets, it contains a blend of probiotic strains, fructooligosaccharides (FOS) as a prebiotic, and zinc sulfate. It is designed to support digestive health, restore and maintain healthy gut microbiota, and manage gastrointestinal conditions such as diarrhea. The probiotics help restore beneficial gut flora, FOS selectively stimulates the growth of these beneficial microbes, and zinc sulfate supports mucosal integrity and immune function in the gastrointestinal tract.
- Brand names
- BelliticsBellitics Sachets
- Other names
- probiotics + FOS + zinc sulfateprobiotics + FOS + zinc sulphateprobiotics + fructooligosaccharides + zinc sulfateprobiotics + fructooligosaccharides + zinc sulphate
Beyond the preview
Go deeper on Bellitics.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bellitics.